Stay updated on Semaglutide Once-weekly vs Placebo add-on to SGLT-2i in T2DM Clinical Trial

Sign up to get notified when there's something new on the Semaglutide Once-weekly vs Placebo add-on to SGLT-2i in T2DM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Semaglutide Once-weekly vs Placebo add-on to SGLT-2i in T2DM Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The error page’s footer revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-19T13:43:55.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The revision label in the footer changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-12T14:28:51.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study details with a simple Home link and access restriction.
    Difference
    20%
    Check dated 2026-09-21T22:44:14.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.5 to v3.6.6. This reflects a small update to the page's versioning/metadata rather than substantive changes to the study content.
    Difference
    0.0%
    Check dated 2026-08-31T17:45:39.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The entry 2016 ( U.S. NIH Grant/Contract ) was added to the trial's list of identifiers, indicating a U.S. NIH funding attribution. This clarifies the funding source associated with the study.
    Difference
    0.0%
    Check dated 2026-08-24T19:20:31.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    A newer revision tag (v3.6.5) was added, replacing the previous revision (v3.6.4) for the study record, indicating an updated version of the page. This update appears to be an internal revision rather than a substantive change to the study details.
    Difference
    0.0%
    Check dated 2026-08-10T12:43:38.000Z thumbnail image

Stay in the know with updates to Semaglutide Once-weekly vs Placebo add-on to SGLT-2i in T2DM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Semaglutide Once-weekly vs Placebo add-on to SGLT-2i in T2DM Clinical Trial page.